Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Japanese introduction for new formulation of epoetin alfa

Feb. 18, 1997

Human Genome Sciences describes MCP-4 polypeptide

Feb. 14, 1997

EPO activators/agonists described by J&J and Affymax

Feb. 14, 1997

Harvard Scientific's impotence drug advances in European trials

Feb. 13, 1997

U.S. patent covers DLK gene

Feb. 13, 1997

PPL reports progress in transgenic cow program

Feb. 13, 1997

AGE inhibitors reported by Kissei

Feb. 13, 1997

NexMed licenses alprostadil cream

Feb. 12, 1997

Menorest approved in 29 markets

Feb. 12, 1997

AGE inhibitors reported by Alteon

Feb. 12, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...